Eli Lilly has named Thomas Fuchs as its first-ever chief artificial intelligence officer (CAIO), bolstering the digital representation in the group's C-suite.Fuchs will take up the newly created role later this month with the goal of providing 'vision, strategic direction and overall leadership of AI initiatives across Lilly, including drug discovery, clinical trials, manufacturing, commercial activities and internal functions.'He was most recently the dean and inaugural department chair for AI and Human Health at Mount Sinai health system, as well as serving as director of the Hasso Plattner Institute for Digital Health and Barbara T Murphy professor for AI and computational pathology at the Icahn School of Medicine.After a wave of appointments of chief digital officers in the last few years, companies, healthcare systems, and government agencies are increasingly looking to add in specialist CAIOs to make sure they stay abreast of the fast-moving technology.Pharma groups are no exception, although many still leave responsibility for AI within the brief of chief digital, chief technology, and chief information officers, according to a recent Gartner report, which says many still prefer to put responsibility for AI below the C-suite, with roles such as global head of AI.Lilly, like all big pharma companies, is deploying AI across its organisation but particularly in drug discovery where, in just one recent example, it signed a $409 million partnership with Genetic Leap to use its AI engine to discover new RNA-targeted medicines.Fuchs has previously held positions at Memorial Sloan Kettering Cancer Center, NASA, and the California Institute of Technology and also founded three companies, including cancer diagnosis startup Paige.AI.

礼来任命托马斯·福斯（ThomasFuchs）为其有史以来的第一任首席人工智能官（CAIO），以支持该集团C-suite中的数字表示。Fuchs将于本月晚些时候担任新职位，目标是“为整个礼来的人工智能计划提供愿景、战略方向和全面领导，包括药物发现、临床试验、制造、商业活动和内部功能。”最近，他担任西奈山卫生系统人工智能和人类健康系主任兼首任系主任，以及哈索·普拉特纳数字健康研究所所长和伊坎医学院人工智能和计算病理学Barbara T Murphy教授。在过去几年中，经过一波首席数字官的任命，公司、医疗保健系统和政府机构越来越多地寻求加入专业CAIO，以确保他们跟上快速发展的技术。加特纳（Gartner）最近的一份报告显示，制药集团也不例外，尽管许多制药集团仍将人工智能的责任置于首席数字官、首席技术官和首席信息官的职权范围内，但许多制药集团表示，许多制药集团仍然倾向于将人工智能的责任置于C-suite之下，担任人工智能的全球负责人。礼来与所有大型制药公司一样，正在其整个组织中部署人工智能，特别是在药物发现方面，最近的一个例子是，礼来与Genetic Leap签署了4.09亿美元的合作伙伴关系，以使用其人工智能引擎发现新的RNA靶向药物。福斯此前曾在美国宇航局纪念斯隆·凯特琳癌症中心和加州理工学院任职，并成立了三家公司，包括癌症诊断初创公司Paige。人工智能。

He holds a doctoral degree in machine le.

他拥有机械工程博士学位。